Philip A. Philip

Also affiliated with Wayne State University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 24 papers. Top paper: “SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers”.

SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers

Journal of Clinical Oncology(2024)10.1200/jco-24-01383

N/A

1.1DataRank · unranked

51 citations

Gentry Teng King, Sarah Colby, Aaron J. Scott, Mitesh J. Borad, Laura W. Goff +17 more

Improved Survival With Adjuvant Cyclooxygenase 2 Inhibition in PIK3CA-Activated Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance)

Journal of Clinical Oncology(2024)10.1200/jco.23.01680

N/A

0.944DataRank · unranked

25 citations

Tyler S. Twombly, Chao Ma, Qian Shi, Koichiro Haruki, Kenji Fujiyoshi +17 more

Trastuzumab Plus Pertuzumab Versus Cetuximab Plus Irinotecan in Patients With RAS/BRAF Wild-Type, HER2-Positive, Metastatic Colorectal Cancer (S1613): A Randomized Phase II Trial

Journal of Clinical Oncology(2025)10.1200/jco-24-01710

N/A

0.458DataRank · unranked

9 citations

Katherine A. Guthrie, Benjamin Tan, Crystal S. Denlinger, Marwan Fakih, Michael J. Overman +15 more

Molecular differences between lymph nodes and distant metastases compared with primaries in colorectal cancer patients

npj Precision Oncology(2021)10.1038/s41698-021-00230-y

N/A

0.449DataRank · unranked

19 citations

Andreas Seeber, Joanne Xiu, Richard M. Goldberg, Davide Soldato, Axel Grothey +16 more

CCR5 and CCL5 gene expression in colorectal cancer: comprehensive profiling and clinical value

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-007939

N/A

0.416DataRank · unranked

15 citations

Yasmine Baca, Joshua Millstein, Yan Yang, Joanne Xiu, Hiroyuki Arai +24 more

Utilizing Patient Input in Rectal Cancer Trial Design

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf074

N/A

0.241DataRank · unranked

4 citations

Wini Zambare, Manju George, Reese Garcia, Phuong Gallagher, Caleah Kitchens +22 more

S2303: phase II/III trial of paclitaxel + ramucirumab ± nivolumab in gastric and esophageal adenocarcinoma (PARAMUNE)

Future Oncology(2025)10.1080/14796694.2025.2485020

N/A

0.176DataRank · unranked

2 citations

Sarah Colby, Paul E. Oberstein, Dan G. Duda, Robin Park, Rajiv Agarwal +12 more

Molecular analysis of XPO1 inhibitor and gemcitabine–nab‐paclitaxel combination in KPC pancreatic cancer mouse model

Clinical and Translational Medicine(2023)10.1002/ctm2.1513

N/A

0DataRank · unranked

17 citations

Mohammad Najeeb Al‐Hallak, Husain Yar Khan, Amro Aboukameel, Yiwei Li, Sahar F. Bannoura +14 more

Anticancer Efficacy of KRASG12C Inhibitors Is Potentiated by PAK4 Inhibitor KPT9274 in Preclinical Models of KRAS G12C-Mutant Pancreatic and Lung Cancers

Molecular Cancer Therapeutics(2023)10.1158/1535-7163.mct-23-0251

N/A

0DataRank · unranked

13 citations

Misako Nagasaka, Amro Aboukameel, Osama Alkhalili, Md. Hafiz Uddin, Sahar F. Bannoura +15 more

Adjuvant Chemoradiation in Patients with Lymph Node-Positive Biliary Tract Cancers: Secondary Analysis of a Single-Arm Clinical Trial (SWOG 0809)

Annals of Surgical Oncology(2023)10.1245/s10434-022-12863-9

N/A

0DataRank · unranked

13 citations

Sarah Colby, David P. Horowitz, Katherine A. Guthrie, Edgar Ben‐Josef, Anthony B. El-Khoueiry +6 more

Anticancer efficacy of KRASG12C inhibitors is potentiated by PAK4 inhibitor KPT9274 in preclinical models of KRASG12C mutant pancreatic and lung cancers

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.03.27.534309

N/A

0DataRank · unranked

3 citations

Misako Nagasaka, Amro Aboukameel, Osama Alkhalili, Md. Hafiz Uddin, Sahar F. Bannoura +15 more

Calcium Release-Activated Calcium (CRAC) Channel Inhibition Suppresses Pancreatic Ductal Adenocarcinoma Cell Proliferation and Patient-Derived Tumor Growth

Cancers(2020)10.3390/cancers12030750

N/A

0DataRank · unranked

38 citations

Gabriel Mpilla, Rachel Sexton, Srikant Viswanadha, Kumar V. Penmetsa, Amro Aboukameel +10 more

Data from Randomized Phase II Study of PARP Inhibitor ABT-888 (Veliparib) with Modified FOLFIRI versus FOLFIRI as Second-line Treatment of Metastatic Pancreatic Cancer: SWOG S1513

(2023)10.1158/1078-0432.c.6531176.v1

N/A

0DataRank · unranked

0 citations

Katherine A. Guthrie, Philip A. Philip, Elizabeth M. Swisher, Florencia G. Jalikis, Michael J. Pishvaian +11 more

Data from Inhibitor of the Nuclear Transport Protein XPO1 Enhances the Anticancer Efficacy of KRAS G12C Inhibitors in Preclinical Models of KRAS G12C–Mutant Cancers

(2023)10.1158/2767-9764.c.6550541

N/A

0DataRank · unranked

0 citations

Misako Nagasaka, Yiwei Li, Amro Aboukameel, Md. Hafiz Uddin, Rachel Sexton +13 more

Variation in FOLFOX, FOLFIRI, and FOLFOXIRI effects on CD8+ T cell and PDL1 levels in MSS CRC patients.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.3526

N/A

0DataRank · unranked

0 citations

Andrew Elliott, Marzia Capelletti, Emil Lou, John L. Marshall, Heinz‐Josef Lenz +10 more

RCC1 regulation of subcellular protein localization via Ran GTPase drives pancreatic ductal adenocarcinoma growth

Cancer Letters(2024)10.1016/j.canlet.2024.217275

N/A

0DataRank · unranked

6 citations

Amro Aboukameel, Husain Yar Khan, Md. Hafiz Uddin, Hyejeong Jang, Eliza W. Beal +13 more

Chemotherapy dose density is prognostic for overall survival in patients with resectable pancreas cancer: A landmark analysis of SWOG 1505

Cancer(2025)10.1002/cncr.35759

N/A

0DataRank · unranked

2 citations

Sarah Colby, Davendra Sohal, Katherine A. Guthrie, Lisa A. Kachnic, E. Gabriela Chiorean +6 more

Data from Randomized Phase II Study of PARP Inhibitor ABT-888 (Veliparib) with Modified FOLFIRI versus FOLFIRI as Second-line Treatment of Metastatic Pancreatic Cancer: SWOG S1513

(2023)10.1158/1078-0432.c.6531176

N/A

0DataRank · unranked

0 citations

Katherine A. Guthrie, Philip A. Philip, Elizabeth M. Swisher, Florencia G. Jalikis, Michael J. Pishvaian +11 more

Randomized Phase II Study of PARP Inhibitor ABT-888 (Veliparib) with Modified FOLFIRI versus FOLFIRI as Second-line Treatment of Metastatic Pancreatic Cancer: SWOG S1513

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-1789

N/A

0DataRank · unranked

53 citations

Katherine A. Guthrie, Philip A. Philip, Elizabeth M. Swisher, Florencia G. Jalikis, Michael J. Pishvaian +11 more

Non-Coding RNAs in Pancreatic Cancer Diagnostics and Therapy: Focus on lncRNAs, circRNAs, and piRNAs

Cancers(2021)10.3390/cancers13164161

N/A

0DataRank · unranked

31 citations

Mohammed Najeeb Al Hallak, Philip A. Philip, Asfar S. Azmi, Ramzi M. Mohammad, Yiwei Li

High-Risk Features Are Prognostic in dMMR/MSI-H Stage II Colon Cancer

Frontiers in Oncology(2021)10.3389/fonc.2021.755113

N/A

0DataRank · unranked

15 citations

Renjian Jiang, Philip A. Philip, Maria Diab, Madhusmita Behera, Christina Wu +7 more

Molecular profiling of signet-ring-cell carcinoma (SRCC) from the stomach and colon reveals potential new therapeutic targets

Oncogene(2022)10.1038/s41388-022-02350-6

N/A

0DataRank · unranked

54 citations

Kelsey Poorman, Fabio Catalano, Andreas Seeber, Richard M. Goldberg, Mohamed E. Salem +11 more

Targeting Cellular Metabolism With CPI-613 Sensitizes Pancreatic Cancer Cells to Radiation Therapy

Advances in Radiation Oncology(2022)10.1016/j.adro.2022.101122

N/A

0DataRank · unranked

20 citations

Mandana Kamgar, Amro Aboukameel, Sahar F. Bannoura, Brian Y. Chung, Yiwei Li +7 more

Inhibitor of the nuclear transport protein XPO1 enhances the anticancer efficacy of KRAS G12C inhibitors in preclinical models of KRAS G12C mutant cancers

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.01.26.477874

N/A

0DataRank · unranked

1 citations

Misako Nagasaka, Yiwei Li, Amro Aboukameel, Md. Hafiz Uddin, Rachel Sexton +13 more